Microbiotica
PrivateLast Round
Series B
Mar 7, 2022
Est. Valuation
$118.5M
Total Funding Raised
$77.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Microbiotica is a biotechnology company that develops live bacterial therapeutics and biomarkers based on microbiome science.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Microbiotica Comparables
Compare Microbiotica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnteroBiotix | 87% | |
| Exeliom Biosciences | 84% | |
| MRM Health | 83% | |
Microbiotica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 7, 2022 | ||||
| VC Round | Oct 24, 2018 | ||||
| Seed | Dec 19, 2016 |
Key People
Founding team and executive leadership
Microbiotica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IP Group | Series B, Seed |
| Flerie Invest | Series B |
| British Patient Capital | Series B |
| British Patient Capital | Series B |
| Cambridge Innovation Capital | Series B, Seed |
| Flerie AB | Series B |
| Seventure Partners | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 101% MoM.
- Jun 10, 2025
Dr. Robert Tansley appointed as new Chief Medical Officer.
Microbiotica Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Microbiotica's valuation, stock price, and market status.